IPO registrations (S-1, F-1) · Registrants
MusclePharm Corp
- SEC CIK
- 1415684 · filings on EDGAR ↗
- Former names
- Tone in Twenty (2007–2010)
- Registration
- Form S-1, first filed 2008-02-07, last 2022-06-17; 7 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2013-01-17; declared effective 2008-04-11; withdrawal requested 2018-09-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 4721 IRONTON STREET, Denver, CO 80239
- EIN
- 77-0664193
- EDGAR entity type
- operating
- Insiders and CEO pay
- MusclePharm Corp on the corporate pages
Offering terms
- Final price
- $8.00 per share (424B4 filed 2013-01-17)
- Shares sold
- 1,500,000
- Gross proceeds
- $12,000,000 before underwriting discounts and any over-allotment option
- Listing
- OTC under the symbol MSLP.OB
- Lead underwriters
- Aegis Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MUSCLEPHARM CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: MusclePharm Corporation Fuzzy (name and state)
- Business registration: MUSCLEPHARM Corporation Fuzzy (name and state)
- Business registration: MUSCLEPHARM CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: MUSCLEPHARM CORPORATION EXACT (EIN (EXACT))
- Form D issuer: MusclePharm Corp EXACT (CIK (EXACT))
- SEC filer: MusclePharm Corp EXACT (CIK (EXACT))
- Person page: John C Price Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Robert P Mahoney Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 34
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-02-07 | S-1/A | S-1/A (amendment) | Tone in Twenty | 0001415684-08-000007 ↗ |
| 2008-03-13 | S-1/A | S-1/A (amendment) | Tone in Twenty | 0001415684-08-000009 ↗ |
| 2008-04-08 | S-1/A | S-1/A (amendment) | Tone in Twenty | 0001415684-08-000010 ↗ |
| 2008-04-11 | EFFECT | EFFECT (declared effective) | Tone in Twenty | 9999999995-08-001062 ↗ |
| 2010-01-11 | EFFECT | EFFECT (declared effective) | Tone in Twenty | 9999999995-10-000168 ↗ |
| 2010-03-30 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-10-000879 ↗ |
| 2011-09-09 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-11-052208 ↗ |
| 2011-09-27 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-11-054875 ↗ |
| 2011-10-07 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-11-002907 ↗ |
| 2011-12-09 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-11-069262 ↗ |
| 2011-12-29 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-11-072086 ↗ |
| 2012-01-13 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-002273 ↗ |
| 2012-01-19 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-003014 ↗ |
| 2012-01-26 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-12-000320 ↗ |
| 2012-02-14 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-12-008787 ↗ |
| 2012-08-30 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-049061 ↗ |
| 2012-09-14 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-12-002739 ↗ |
| 2012-10-11 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-12-002964 ↗ |
| 2012-10-26 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-12-058112 ↗ |
| 2012-12-19 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-068590 ↗ |
| 2012-12-26 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-069409 ↗ |
| 2012-12-31 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-12-070095 ↗ |
| 2012-12-31 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-000008 ↗ |
| 2013-01-16 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-000196 ↗ |
| 2013-01-17 | 424B4 | 424B4 (final prospectus) | MusclePharm Corp | 0001144204-13-002719 ↗ |
| 2013-05-09 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-001452 ↗ |
| 2013-05-09 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-001458 ↗ |
| 2013-05-13 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-001497 ↗ |
| 2013-06-18 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-13-035487 ↗ |
| 2013-07-15 | S-1/A | S-1/A (amendment) | MusclePharm Corp | 0001144204-13-039542 ↗ |
| 2013-07-17 | EFFECT | EFFECT (declared effective) | MusclePharm Corp | 9999999995-13-002114 ↗ |
| 2013-08-21 | S-1 | S-1 (registration) | MusclePharm Corp | 0001144204-13-047298 ↗ |
| 2018-09-10 | RW | RW (withdrawal request) | MusclePharm Corp | 0001654954-18-010020 ↗ |
| 2022-06-17 | S-1 | S-1 (registration) | MusclePharm Corp | 0001493152-22-017031 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | S-1/A | registration statement | $425.00 | 1,500,000 | $637,500,000 | OTC MSLP.OB | 1 | primary document; price line, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2013-01-17 | 424B4 | final prospectus | $8.00 | 1,500,000 | $12,000,000 | OTC MSLP.OB | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Armenta Leonard K Jr | Director; Officer | Chief Operating Officer | 2 | 2010 | |
| Gregory Cory J | Director,Officer,TenPercentOwner; Officer; Officer,TenPercentOwner; Other | Executive Vice President; President; See Remarks | 10 | 2010–2015 | |
| Huss Todd Edwin | Officer | Chief Financial Officer | 1 | 2010 | |
| Pyatt Brad J | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; President and CEO | 18 | 2010–2015 | |
| Meer Lawrence S | Director,Officer | Chief Financial Officer | 1 | 2010 | |
| Wingate Michael Shawn | Officer | Chief Operating Officer | 1 | 2010 | |
| DELUCA JEREMY R. | Director,Officer,TenPercentOwner; Director,TenPercentOwner | Co-Pres. & Chief Mktg. Ofc.; Co-Pres & Chief Mrktng Offcr | 3 | 2012–2013 | |
| BLUHER JOHN H | Director,Officer; Officer; Other | Chief Operating Officer; EVP - COO | 6 | 2012–2014 | |
| DAVIS LEWIS GARY | Officer | Chief Financial Officer | 5 | 2012–2013 | |
| Groussman Mark | Director | 1 | 2012 | ||
| PROSSER DON | Director; Officer | Chief Financial Officer | 8 | 2012–2014 | |
| Burr Gordon G | Director | 2 | 2012 | ||
| Greenwell James J | Director; Officer | Chief Operating Officer | 12 | 2012–2014 | |
| Doron Michael J | Director | 14 | 2012–2016 | ||
| Estalella Richard | Director; Director,Officer; Officer | Chief Operating Officer; President | 7 | 2013–2016 | |
| mcclory daniel joseph | Director | 3 | 2013–2014 | ||
| ROLLOCK SYDNEY R | Officer | Chief Marketing Officer; Chief Marketing & Sales Off | 4 | 2013–2014 | |
| MACOSKO GREGORY | Director | 3 | 2014 | ||
| Lupo Andrew J | Director | 4 | 2014 | ||
| Price John C | Officer | Chief Financial Officer | 2 | 2015 | person page Fuzzy |
| BUSH WILLIAM JOHN | Director | 8 | 2015–2019 | ||
| Jenkins Stacey Y | Director | 5 | 2015–2016 | ||
| Thompson Noel | Director | 3 | 2015–2016 | ||
| Drexler Ryan Charles | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | CEO; CEO and President; Executive Chairman; See Remarks. | 10 | 2015–2021 | |
| Lynch Peter Christopher | Officer | Chief Financial Officer | 2 | 2016 | |
| Amerop Holdings, Inc. | TenPercentOwner | 6 | 2017–2018 | ||
| LANDES JOSHUA | TenPercentOwner | 20 | 2017–2019 | ||
| OBUS NELSON | TenPercentOwner | 20 | 2017–2019 | ||
| WYNNEFIELD CAPITAL INC | TenPercentOwner | 20 | 2017–2019 | ||
| Wynnefield Capital, Inc. Profit Sharing Plan | TenPercentOwner | 20 | 2017–2019 | ||
| WYNNEFIELD CAPITAL MANAGEMENT LLC | TenPercentOwner | 20 | 2017–2019 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | TenPercentOwner | 20 | 2017–2019 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | TenPercentOwner | 20 | 2017–2019 | ||
| WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD | TenPercentOwner | 20 | 2017–2019 | ||
| Desmond John J | Director | 4 | 2017–2019 | ||
| Wessell Leonard P. III | TenPercentOwner | 2 | 2017–2018 | ||
| BLUNDELL MARK | TenPercentOwner | 6 | 2018–2022 | ||
| Enright Todd M. | TenPercentOwner | 6 | 2018–2022 | ||
| Feagan Donald | TenPercentOwner | 6 | 2018–2022 | ||
| Mahoney Robert P | TenPercentOwner | 6 | 2018–2022 | person page Fuzzy | |
| White Winston Select Asset Fund Series Fund MP-18, LLC | TenPercentOwner | 6 | 2018–2022 | ||
| White Winston Select Asset Funds, LLC | TenPercentOwner | 6 | 2018–2022 | ||
| Heller Michael David | Director | 1 | 2021 | ||
| KARR PAUL W | Director | 1 | 2021 | ||
| Chin Eric | Officer | Chief Accounting Officer | 1 | 2022 | |
| Rizvi Sabina | Director,Officer; Officer | President & CFO | 2 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-12-16 | MusclePharm Corp | Other | $6,000,000 | $6,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MusclePharm Corporation | CO | State business registries | name and state |
| Business registration | MUSCLEPHARM Corporation | CO | State business registries | name and state |
| Business registration | MUSCLEPHARM CORPORATION | CO | State business registries | name and state |
| Plan sponsor | MUSCLEPHARM CORPORATION | NV | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | MusclePharm Corp | CO | Form D private offerings | CIK (EXACT) |
| SEC filer | MusclePharm Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | MUSCLEPHARM CORPORATION | CO | Trademarks (USPTO) | name and state |
| Business registration | MUSCLEPHARM CORPORATION | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | MUSCLEPHARM CORPORATION | EIN (EXACT) | ||
| Person page | John C Price | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Robert P Mahoney | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.